A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and...

Area of Science:

• Biomarker Discovery
• Molecular Diagnostics
• Oncology

Background:

• Colorectal neoplasms, including colorectal cancer (CRC) and advanced adenomas (CAA), are common and screening methods have limitations.
• Current screening lacks sensitivity, specificity, and patient compliance, necessitating improved diagnostic approaches.

Purpose of the Study:

• To develop a novel plasma-based microRNA (miRNA) diagnostic assay for colorectal neoplasms.
• To enhance early detection and specificity for colorectal neoplasia compared to existing methods.

Main Methods:

• Plasma samples from a training cohort (n=60) were screened for 380 miRNAs using microfluidic arrays.
• A mathematical model was developed and validated in independent test (n=120) and validation (n=150) cohorts to predict sample identity.
• Seven specific miRNAs were identified and evaluated for their diagnostic potential.

Main Results:

• Seven miRNAs (miR-21, miR-29c, miR-122, miR-192, miR-346, miR-372, miR-374a) were identified as uniquely dysregulated in colorectal neoplasia.
• The assay demonstrated high diagnostic accuracy, with Area Under the Curve (AUC) values ranging from 0.79 to 0.98 for various comparisons.
• The prediction model achieved 69-90% accuracy in the validation cohort.

Conclusions:

• The developed plasma miRNA assay and prediction model offer a promising tool for differentiating colorectal neoplasia.
• This approach demonstrates superior sensitivity and specificity compared to current clinical screening standards for colorectal neoplasms.